Business
AML patient achieves Complete Response in CHM CORE-NK trial
AML patient achieves Complete Response in CHM CORE-NK trial
About this update from Chimeric Therapeutics Limited
Chimeric Therapeutics Ltd has released a press release. View Attachment
View stock analysis, news, and events for Chimeric Therapeutics Limited